ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 386 filers reported holding ENCOMPASS HEALTH CORP in Q2 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,210,444 | -19.5% | 122,252 | -18.9% | 1.72% | -15.4% |
| Q2 2023 | $10,203,491 | -6.7% | 150,694 | -25.5% | 2.04% | -10.5% |
| Q1 2023 | $10,940,751 | -33.2% | 202,232 | -26.2% | 2.28% | -31.4% |
| Q4 2022 | $16,390,512 | +53.9% | 274,043 | +16.4% | 3.32% | +69.7% |
| Q3 2022 | $10,653,000 | +23.7% | 235,527 | +53.3% | 1.96% | +31.8% |
| Q2 2022 | $8,610,000 | +2.2% | 153,611 | +29.7% | 1.49% | +17.9% |
| Q1 2022 | $8,424,000 | -10.9% | 118,463 | -18.3% | 1.26% | -6.5% |
| Q4 2021 | $9,459,000 | +26.3% | 144,950 | +45.2% | 1.35% | -1.2% |
| Q3 2021 | $7,489,000 | +15.9% | 99,795 | +20.5% | 1.36% | +9.6% |
| Q2 2021 | $6,461,000 | -0.9% | 82,803 | +4.0% | 1.24% | -9.2% |
| Q1 2021 | $6,518,000 | -5.9% | 79,581 | -5.0% | 1.37% | -9.6% |
| Q4 2020 | $6,928,000 | -33.5% | 83,780 | -47.7% | 1.52% | -37.0% |
| Q3 2020 | $10,412,000 | +26.9% | 160,234 | +20.9% | 2.41% | +25.3% |
| Q2 2020 | $8,205,000 | +83.1% | 132,494 | +89.3% | 1.92% | +20.3% |
| Q1 2020 | $4,482,000 | -35.8% | 70,005 | -30.5% | 1.60% | -15.1% |
| Q4 2019 | $6,977,000 | – | 100,722 | – | 1.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 400,000 | $25,612,000 | 9.91% |
| REINHART PARTNERS, LLC. | 687,133 | $43,997,000 | 4.26% |
| RK Capital | 147,290 | $9,431,000 | 4.24% |
| HealthCor Management, L.P. | 1,525,809 | $97,698,000 | 4.18% |
| Integral Health Asset Management, LLC | 115,000 | $7,363,000 | 3.24% |
| Sivik Global Healthcare LLC | 32,500 | $7,733,000 | 3.05% |
| Copeland Capital Management, LLC | 635,514 | $40,692,000 | 2.48% |
| Rock Springs Capital Management LP | 815,000 | $52,184,000 | 2.16% |
| Endurant Capital Management LP | 55,614 | $3,561,000 | 1.61% |
| Advantage Alpha Capital Partners LP | 70,005 | $4,482,000 | 1.60% |